Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dominic Oliver


Postdoctoral Researcher

I am a Postdoctoral Researcher working with Professor Philip McGuire. My interests lie in prevention of psychosis and other severe mental disorders, particularly in combining prediction modelling methods with routinely collected data to improve identification of individuals at risk, predict their clinical outcomes and their response to interventions. 

My main role involves biomarker acquisition and analysis on the Stratification and Treatment in Early Psychosis (STEP) programme. STEP is three large scale, international multi-centre clinical trials of cannabidiol (CBD) in different stages of early psychosis: 1) Clinical high risk for psychosis; 2) First episode psychosis and; 3) Treatment resistant psychosis. 

I completed my PhD in 2022 ("Improving prediction of psychosis risk") at the Institute of Psychiatry, Psychology & Neuroscience, King's College London, under the supervision of Professor Paolo Fusar-Poli and Professor Philip McGuire. In addition to colleagues at University of Oxford, I have continued collaborations at King's College London.

Recent publications

More publications